Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCash from Financing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesChange in TaxesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Dna X (SONM) Other Working Capital Changes (2018 - 2025)

Historic Other Working Capital Changes for Dna X (SONM) over the last 8 years, with Q3 2025 value amounting to -$1.4 million.

  • Dna X's Other Working Capital Changes fell 8469.66% to -$1.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $1.5 million, marking a year-over-year increase of 16513.27%. This contributed to the annual value of $2.9 million for FY2024, which is 3753564.41% up from last year.
  • According to the latest figures from Q3 2025, Dna X's Other Working Capital Changes is -$1.4 million, which was down 8469.66% from $462000.0 recorded in Q2 2025.
  • In the past 5 years, Dna X's Other Working Capital Changes ranged from a high of $2.3 million in Q4 2024 and a low of -$1.5 million during Q1 2021
  • Its 5-year average for Other Working Capital Changes is $107293.3, with a median of $7833.0 in 2023.
  • The largest annual percentage gain for Dna X's Other Working Capital Changes in the last 5 years was 1430061.28% (2024), contrasted with its biggest fall of 977700.75% (2024).
  • Over the past 5 years, Dna X's Other Working Capital Changes (Quarter) stood at $2.1 million in 2021, then plummeted by 129.48% to -$630000.0 in 2022, then soared by 88.25% to -$74000.0 in 2023, then skyrocketed by 3220.27% to $2.3 million in 2024, then plummeted by 160.63% to -$1.4 million in 2025.
  • Its Other Working Capital Changes was -$1.4 million in Q3 2025, compared to $462000.0 in Q2 2025 and $127000.0 in Q1 2025.